Skip to main content

Table 5 Comparision for 4 models and clinical features

From: Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma

Characteristics C-index (95%CI) 1-year AUC (95%CI) 3-year AUC (95%CI) 5-year AUC (95%CI)
T 0.50 (0.426–0.583, 0.571) 0.53 (0.47–0.6) 0.52 (0.46–0.58) 0.6 (0.52–0.67)
N 0.53 (0.452–0.610,0.835) 0.52 (0.47–0.59) 0.53 (0.47–0.59) 0.45 (0.46–0.54)
Age 0.56 (0.490–0.626,0.0096) 0.62 (0.53–0.71) 0.55 (0.48–0.62) 0.51 (0.42–0.6)
AJCC stage 0.52 (0.434–0.600,0.412) 0.56 (0.5–0.63) 0.58 (0.52–0.64) 0.5 (0.41–0.59)
14-IGPS signature 0.78 (0.693–0.859,3.65E-08) 0.73 (0.66–0.8) 0.82 (0.77–0.87) 0.75 (0.66–0.82)
3-gene signature 0.67 (0.579–0.767, 0.002) 0.56 (0.48–0.63) 0.64 (0.57–0.71) 0.63 (0.52–0.74)
6-gene signature 0.65 (0.560–0.750, 7.07E-5) 0.56 (0.48–0.63) 0.63 (0.56–0.7) 0.71 (0.62–0.81)
3-gene signature 0.62 (0.519–0.715,0.043 0.59 (0.50–0.67) 0.58 (0.51–0.66) 0.51 (0.40–0.61)